SCHEMBL1025375

SCHEMBL1025375

COc1cc(F)c(C=Nc2ccc(C(F)(F)F)nc2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.40
CA2 P00918 2/20 0.36
PTGS1 P23219 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
CA1 P00915 1/20 0.35
STIM1 Q13586 1/20 0.35
ORAI1 Q96D31 1/20 0.35
TRPV4 Q9HBA0 1/20 0.34
PDE10A Q9Y233 1/20 0.34
CYP3A4 P08684 2/20 0.34
KMT2A Q03164 2/20 0.33
FPR1 P21462 1/20 0.33
FPR2 P25090 1/20 0.33
MDM2 Q00987 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025374 1.00 PTGS2 (0.40) PTGS2CA2PTGS1CA12CA9
SCHEMBL1225545 0.74 ALDH1A1 (0.42) PTGS2KMT2ACYP1A2MAPTRAB9A
SCHEMBL1225547 0.74 ALDH1A1 (0.42) PTGS2KMT2ACYP1A2MAPTRAB9A
SCHEMBL14833594 0.71 CYP1A2 (0.47) PTGS2CA2PTGS1CA12CA9
SCHEMBL14833593 0.71 CYP1A2 (0.47) PTGS2CA2PTGS1CA12CA9
SCHEMBL19953040 0.70 KMT2A (0.50) PTGS2CA2PTGS1CA12CA9
SCHEMBL929327 0.69 TRPV4 (0.52) PTGS2CA2PTGS1CA12CA9
SCHEMBL31130640 0.67 TRPV4 (0.50) PTGS2CA2PTGS1CA12CA9
SCHEMBL17366564 0.65 TRPV4 (0.44) TRPV4CYP2C9
SCHEMBL1246261 0.65 TRPV4 (0.52) TRPV4PDE10ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011056463-A2 FUNGICIDAL MIXTURES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-05-12 WO disclosed
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-02-24 US disclosed
EP-2274284-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. Du Pont de Nemours and Company (US) 2011-01-19 EP disclosed
WO-2009137538-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed
WO-2009137651-A2 FUNGICIDAL SUBSTITUTED AZOLES E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-11-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110045101-A1 FUNGICIDAL SUBSTITUTED AZOLES CBR3, NOX3, CBR1 PTGS2 3691/4885CA2 364/4885PTGS1 3823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.